The Greenlight Capital funds returned -4.3% in Q2 2026 and 1.9% YTD, each net of fees and expenses. Read more here.
Expectations for Wnt pathway-targeting trispecific antibody remigromig (MK-3000, formerly known as EYE103) were riding high ...
We added several new, small long positions during the quarter, such as Comcast, Fortune Brands Innovations, Primo Brands, ...
Abrupt network reshuffling hands nonstop links to Brisbane, Doha and Paris to rivals as demand patterns shift seasonally.
8hon MSN
Open enrollment is underway, but switching from Medicare Advantage to Medicare can be difficult
Medicare Open enrollment has begun. Those who want to switch from Medicare Advantage to traditional Medicare may be in for a ...
Remigromig demonstrated non-inferiority in mean change from baseline in best corrected visual acuity versus ranibizumab at one year in patients with diabetic macular ...
Oura Ring is chasing a $2 billion IPO on the promise that doctors want its health data, but there is a catch millions of ...
Sky Simulations has released version 3.1.0 for its DC-9 Series 21, 41 and 51 package for Microsoft Flight Simulator 2024.
October 12, 2026) - Frost & Sullivan officially released the 2026 Global Gene Therapy Industry Development Blue Book in October 2026, in collaboration with industry partners. The report systematically ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new one-year data from the Phase III ...
Florida is saving a massive amount of money on Medicaid spending amid a crackdown on fraud. On Tuesday 6, Governor Ron DeSantis‘s office issued a press release saying the state has focused ...
Merck (NYSE:MRK) reported one year pivotal Phase 2b/3 data for remigromig in diabetic macular edema, showing non inferior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results